Literature DB >> 10694187

Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats.

A Cabassi1, J F Bouchard, E C Dumont, H Girouard, M Le Jossec, D Lamontagne, J G Besner, J de Champlain.   

Abstract

OBJECTIVES: To investigate the effect of chronic antioxidant treatments on the development of nitrate tolerance in spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats by evaluating (i) coronary vascular reactivity, (ii) lipid peroxidation (malondialdehyde), and (iii) peroxynitrite formation (3-nitrotyrosine).
METHODS: Tolerance was induced in 16-week-old male SHR and WKY, by 4 days of continuous treatment with nitroglycerin patches. Two groups were orally pre-treated (2-weeks) with antioxidants: N-acetyl-L-cysteine (NAC) or melatonin. Effects of serotonin (5-HT) and sodium nitroprusside (SNP) perfusion were tested in isolated Langendorff-perfused hearts. 3-Nitrotyrosine levels were measured in coronary sinus effluent and malondialdehyde in plasma.
RESULTS: Nitrate tolerance reduced SNP-induced dilation in both strains. This alteration was differently improved by antioxidants: melatonin was effective in SHR, whereas NAC was effective in WKY. Tolerance also reduced 5-HT-mediated vasodilation in WKY, which was reversed by both antioxidants. By contrast, nitrate tolerance enhanced the vasoconstriction to 5-HT in SHR and both antioxidants prevented this response. Furthermore, tolerance was associated with higher malondialdehyde levels in both strains and with higher 3-nitrotyrosine levels in SHR. These changes were reversed by both antioxidants.
CONCLUSIONS: A participation of oxidative stress was suggested during nitrate tolerance development, since antioxidants prevented the increase in lipid peroxidation and improved vascular responses to SNP and 5HT. Differential effects of antioxidants on SNP-induced vasodilation in SHR and WKY may suggest distinct mechanisms of tolerance development in hearts from hypertensive and normotensive rats. An increased peroxynitrite generation, expressed by higher 3-nitrotyrosine levels, could contribute to nitrate tolerance in the coronary circulation of SHR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694187     DOI: 10.1097/00004872-200018020-00009

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  5 in total

1.  Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease.

Authors:  Carmen De Miguel; Chuanling Guo; Hayley Lund; Di Feng; David L Mattson
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-15

Review 2.  A physiologically relevant role for NO stored in vascular smooth muscle cells: A novel theory of vascular NO signaling.

Authors:  Taiming Liu; Hobe Schroeder; Gordon G Power; Arlin B Blood
Journal:  Redox Biol       Date:  2022-05-09       Impact factor: 10.787

3.  Evidence for a Prehypertensive Water Dysregulation Affecting the Development of Hypertension: Results of Very Early Treatment of Vasopressin V1 and V2 Antagonism in Spontaneously Hypertensive Rats.

Authors:  Ignazio Verzicco; Stefano Tedeschi; Gallia Graiani; Alice Bongrani; Maria Luisa Carnevali; Simona Dancelli; Jessica Zappa; Silvia Mattei; Achiropita Bovino; Stefania Cavazzini; Rossana Rocco; Anna Calvi; Barbara Palladini; Riccardo Volpi; Valentina Cannone; Pietro Coghi; Alberico Borghetti; Aderville Cabassi
Journal:  Front Cardiovasc Med       Date:  2022-06-01

4.  High renin hypertension in focal renal fibromuscular dysplasia: turn off of renin system angiotensin overactivation by renal angioplasty cured high blood pressure and quickly reversed myocardial hypertrophy.

Authors:  Simona Merla; Riccardo Simoni; Stefano Tedeschi; Massimiliano Ferrari; Giovanni Passeri; Carla Marcato; Enrico Epifani; Ignazio Semproni; Giulia Zini; Ignazio Verzicco; Pietro Coghi; Riccardo Volpi; Aderville Cabassi
Journal:  Acta Biomed       Date:  2021-04-30

Review 5.  Mitochondrial mechanosensor in cardiovascular diseases.

Authors:  Cristina Caffarra Malvezzi; Aderville Cabassi; Michele Miragoli
Journal:  Vasc Biol       Date:  2020-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.